[go: up one dir, main page]

AU6405680A - Thromboxane synthase inhibitors + their therapeutic use - Google Patents

Thromboxane synthase inhibitors + their therapeutic use

Info

Publication number
AU6405680A
AU6405680A AU64056/80A AU6405680A AU6405680A AU 6405680 A AU6405680 A AU 6405680A AU 64056/80 A AU64056/80 A AU 64056/80A AU 6405680 A AU6405680 A AU 6405680A AU 6405680 A AU6405680 A AU 6405680A
Authority
AU
Australia
Prior art keywords
therapeutic use
synthase inhibitors
thromboxane synthase
thromboxane
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU64056/80A
Other versions
AU531604B2 (en
Inventor
James G. Hamilton
William E.M. Lands
Ann Clare Sullivan
Lawrence D. Tobias
Joseph Triscari
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU6405680A publication Critical patent/AU6405680A/en
Application granted granted Critical
Publication of AU531604B2 publication Critical patent/AU531604B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU64056/80A 1979-11-02 1980-11-03 Thromboxane synthase inhibitors + their therapeutic use Ceased AU531604B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US9085079A 1979-11-02 1979-11-02
US9094179A 1979-11-02 1979-11-02
US90941 1979-11-02
US90850 1979-11-02
US10748479A 1979-12-26 1979-12-26
US107484 1993-08-17

Publications (2)

Publication Number Publication Date
AU6405680A true AU6405680A (en) 1981-05-07
AU531604B2 AU531604B2 (en) 1983-09-01

Family

ID=27376677

Family Applications (1)

Application Number Title Priority Date Filing Date
AU64056/80A Ceased AU531604B2 (en) 1979-11-02 1980-11-03 Thromboxane synthase inhibitors + their therapeutic use

Country Status (4)

Country Link
EP (1) EP0028410B1 (en)
AU (1) AU531604B2 (en)
DE (2) DE3041090A1 (en)
NL (1) NL8005946A (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2109931A1 (en) * 1992-03-27 1993-10-14 Hiroshi Matsui Novel imidazole derivative, pharmaceutical use thereof, and intermediate therefor
US6410562B1 (en) 1998-12-18 2002-06-25 Eli Lilly And Company Hypoglycemic imidazoline compounds
AU2002310765B2 (en) * 2001-06-18 2007-10-18 Laboratoires Serono Sa Alkylidene pyrazolidinedione derivatives and use for treating diabetes and obesity

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637731A (en) * 1968-07-18 1972-01-25 Du Pont 1-(alkylsubstituted phenyl)imidazoles useful in acth reserve assay
GB1447031A (en) * 1972-05-19 1976-08-25 Wellcome Found Tricyclic sulphones and pharmaceutical compositions containing them
EP0003901B1 (en) * 1978-02-24 1981-08-05 Pfizer Limited 3-(imidazol-1-ylalkyl)indoles as selective inhibitors of thromboxane synthetase,pharmaceutical compositions thereof, and methods for preparing them

Also Published As

Publication number Publication date
EP0028410B1 (en) 1987-09-30
AU531604B2 (en) 1983-09-01
DE3072035D1 (en) 1987-11-05
EP0028410A1 (en) 1981-05-13
NL8005946A (en) 1981-06-01
DE3041090A1 (en) 1981-09-03

Similar Documents

Publication Publication Date Title
AU537351B2 (en) Iodine adhesive
AU533697B2 (en) Quasi-synthetic genes
AU524782B2 (en) Sterilisation methods
AU518076B2 (en) Packed column
AU538496B2 (en) Methods
AU538761B2 (en) Tattooing apparatus
AU527396B2 (en) Bale-shape gauge
AU534782B2 (en) Abrasive body
AU522526B2 (en) Abrasive body
AU5885680A (en) Anhydrous ethanol
AU6198680A (en) Precision seeder
AU528671B2 (en) Body fluid-purifying apparatus
AU535803B2 (en) Corrosion inhibitor
AU5484080A (en) Electro-mechanical transducer
AU514558B2 (en) Scale inhibitors
AU520682B2 (en) Lipogensis inhibitors
GB2048857B (en) -lactamase inhibitors
AU531604B2 (en) Thromboxane synthase inhibitors + their therapeutic use
AU536678B2 (en) Note dispenser
AU533619B2 (en) Corrosion inhibitors
AU520504B2 (en) Schistosomiasis therapy
AU6258280A (en) Analgesic
AU5883680A (en) Improved vice
AU534533B2 (en) Iontophoresis apparatus
AU5550780A (en) Alpha-halomethyl amines